Discover 938 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 938
Active & Responsive
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
for
Asthma
Location: Clackamas OR, Portland OR, Sacramento CA, Walnut Creek CA,
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Sex: All
Age: 12+
Code: NCT06664619
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
for
Small Cell Lung Cancer
Location: Portland OR, Chicago IL, Nashville TN, Buffalo NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780137
Phase1, Phase2, Recruiting
Active & Responsive
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
for
Advanced Liver Cancers
Location: Portland OR, San Francisco CA, Santa Monica CA, Duarte CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT04524871
Phase1, Phase2, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Salem OR, Olympia WA, Tacoma WA, Medford OR, Boise ID,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase3, Recruiting
Mobility Rehab, a Therapist-assisted System for Gait Rehabilitation
for
Parkinson Disease, Stroke, Multiple Sclerosis,
Location: Salem OR
Sponsor: Oregon Health and Science University
Sex: All
Age: 60 - 70+
Code: NCT03869879
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence